NOW ENROLLING
Are You Taking Semaglutide or Tirzepatide? You May Be Eligible to Join Research Studies.
About Our Studies
Eligible participants are adults ages 18 to 70 who have maintained a stable weekly dose of semaglutide or tirzepatide for weight management for at least 2 months. Participants will transition to the investigational study medication as part of the study and must be willing to attend scheduled study visits and complete all required study procedures.
Participation includes study-related medical care, health assessments, and regular monitoring by a team of medical professionals.
Participants May Receive:
- Study-related care and monitoring at no cost
- Care and attention from a dedicated clinical research team
- Study-related tests and evaluations provided at no charge
- Compensation for time and travel may be available
- No health insurance required for participation
- All study-related visits and procedures are scheduled in advance.
You may be able to participate if you:
- • Are 18 to 70 years old
- • Are living with overweight or obesity
- • Have been taking a stable weekly dose of semaglutide or tirzepatide for weight management for at least 2 months
- • Are willing to switch from semaglutide or tirzepatide to the investigational study medication
- • Are not currently pregnant or breastfeeding and willing to use contraception during study participation
About Weight Management with Semaglutide or Tirzepatide
Living with overweight or obesity can affect overall health and quality of life. Many people use prescription medications such as semaglutide or tirzepatide alongside healthy lifestyle habits to help manage their weight. While these medications have become an important treatment option for many adults, researchers continue to study new investigational medications to learn more about how they are processed by the body.
To see if you are eligible, please complete the form to get in touch with the study team.
Your privacy is important to us. By completing the following pre-screener you agree to our Privacy Policy and Terms of Use, and agree that we may retain the personal information you provide and share it with personnel involved in the study, or otherwise as described in the Privacy Policy, and we or our affiliates may contact you by phone using automated technology or pre-recorded voicemail or other means including but not limited to text messages (standard messaging rates may apply) regarding research studies.